These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 9619788)
1. Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders. Maa YF; Nguyen PA; Andya JD; Dasovich N; Sweeney TD; Shire SJ; Hsu CC Pharm Res; 1998 May; 15(5):768-75. PubMed ID: 9619788 [TBL] [Abstract][Full Text] [Related]
2. Protein inhalation powders: spray drying vs spray freeze drying. Maa YF; Nguyen PA; Sweeney T; Shire SJ; Hsu CC Pharm Res; 1999 Feb; 16(2):249-54. PubMed ID: 10100310 [TBL] [Abstract][Full Text] [Related]
3. The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody. Andya JD; Maa YF; Costantino HR; Nguyen PA; Dasovich N; Sweeney TD; Hsu CC; Shire SJ Pharm Res; 1999 Mar; 16(3):350-8. PubMed ID: 10213364 [TBL] [Abstract][Full Text] [Related]
4. Stabilization of IgG1 in spray-dried powders for inhalation. Schüle S; Schulz-Fademrecht T; Garidel P; Bechtold-Peters K; Frieb W Eur J Pharm Biopharm; 2008 Aug; 69(3):793-807. PubMed ID: 18477504 [TBL] [Abstract][Full Text] [Related]
5. Effects of Moisture-Induced Crystallization on the Aerosol Performance of Spray Dried Amorphous Ciprofloxacin Powder Formulations. Shetty N; Zeng L; Mangal S; Nie H; Rowles MR; Guo R; Han Y; Park JH; Zhou QT Pharm Res; 2018 Jan; 35(1):7. PubMed ID: 29294198 [TBL] [Abstract][Full Text] [Related]
6. Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery. Chan HK; Clark A; Gonda I; Mumenthaler M; Hsu C Pharm Res; 1997 Apr; 14(4):431-7. PubMed ID: 9144727 [TBL] [Abstract][Full Text] [Related]
7. Physical stability of salmon calcitonin spray-dried powders for inhalation. Chan HK; Clark AR; Feeley JC; Kuo MC; Lehrman SR; Pikal-Cleland K; Miller DP; Vehring R; Lechuga-Ballesteros D J Pharm Sci; 2004 Mar; 93(3):792-804. PubMed ID: 14762916 [TBL] [Abstract][Full Text] [Related]
8. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders. Yu J; Chan HK; Gengenbach T; Denman JA Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664 [TBL] [Abstract][Full Text] [Related]
9. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders. Yu J; Romeo MC; Cavallaro AA; Chan HK Int J Pharm; 2018 Apr; 541(1-2):11-18. PubMed ID: 29454904 [TBL] [Abstract][Full Text] [Related]
10. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders. Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252 [TBL] [Abstract][Full Text] [Related]
11. Spray-drying performance of a bench-top spray dryer for protein aerosol powder preparation. Maa YF; Nguyen PA; Sit K; Hsu CC Biotechnol Bioeng; 1998 Nov; 60(3):301-9. PubMed ID: 10099432 [TBL] [Abstract][Full Text] [Related]
12. Spray-Dried and Spray-Freeze-Dried Powder Formulations of an Anti-Interleukin-4Rα Antibody for Pulmonary Delivery. Pan HW; Seow HC; Lo JCK; Guo J; Zhu L; Leung SWS; Zhang C; Lam JKW Pharm Res; 2022 Sep; 39(9):2291-2304. PubMed ID: 35879500 [TBL] [Abstract][Full Text] [Related]
13. Understanding the impact of mannitol on physical stability and aerosolization of spray-dried protein powders for inhalation. Arte KS; Tower CW; Mutukuri TT; Chen Y; Patel SM; Munson EJ; Tony Zhou Q Int J Pharm; 2024 Jan; 650():123698. PubMed ID: 38081559 [TBL] [Abstract][Full Text] [Related]
14. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale. Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715 [TBL] [Abstract][Full Text] [Related]
15. Aerosolization properties, surface composition and physical state of spray-dried protein powders. Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594 [TBL] [Abstract][Full Text] [Related]
16. The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin. Momin MAM; Tucker IG; Das SC Drug Dev Ind Pharm; 2019 Jul; 45(7):1205-1213. PubMed ID: 30990097 [TBL] [Abstract][Full Text] [Related]
17. Dry powders for inhalation containing monoclonal antibodies made by thin-film freeze-drying. Hufnagel S; Xu H; Sahakijpijarn S; Moon C; Chow LQM; Williams Iii RO; Cui Z Int J Pharm; 2022 Apr; 618():121637. PubMed ID: 35259440 [TBL] [Abstract][Full Text] [Related]
18. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers. Zeng XM; MacRitchie HB; Marriott C; Martin GP Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863 [TBL] [Abstract][Full Text] [Related]
19. Co-spray dried hydrophobic drug formulations with crystalline lactose for inhalation aerosol delivery. Ke WR; Kwok PCL; Khanal D; Chang RYK; Chan HK Int J Pharm; 2021 Jun; 602():120608. PubMed ID: 33862136 [TBL] [Abstract][Full Text] [Related]
20. Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders. Brunaugh AD; Wu T; Kanapuram SR; Smyth HDC Mol Pharm; 2019 Oct; 16(10):4165-4180. PubMed ID: 31448924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]